Home-based exercise program for patients with pulmonary embolism
Official title: Mobility Outcomes in Post-Pulmonary Embolic Disease (MOPED): A Pilot Feasibility Prospective Randomized Trial
Run by Mayo Clinic · NCT06695247 · Data updated 2026-11-12
This study is testing a home-based exercise program to help people recovering from pulmonary embolism improve their mobility and overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | July 14, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT06695247 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with acute intermediate-risk or high-risk pulmonary embolism who exhibit specific imaging characteristics.
✕Probably not a fit
Patients with chronic pulmonary conditions or those not meeting the acute pulmonary embolism criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve mobility outcomes for patients recovering from pulmonary embolism by implementing a home-based exercise program. The program is designed through the collaboration of cardiovascular medicine specialists and cardiac physiologists, utilizing an Interactive Care Plan to guide patients in their rehabilitation. Participants will engage in structured exercise training tailored to their specific needs and conditions. The study focuses on patients with acute intermediate-risk and high-risk pulmonary embolism, as identified through imaging techniques.
Why it matters
Potential benefit: If successful, this program could enhance recovery and mobility for patients suffering from pulmonary embolism.
How similar studies have gone: Other studies have shown positive outcomes with home-based exercise interventions for similar conditions, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Acute intermediate-risk PE, defined as: * Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND * Evidence of right ventricular enlargement by computed tomography (RV to LV ratio \>1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition. Acute high-risk PE, defined as: * Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND * Evidence of right ventricular enlargement by computed tomography (RV to LV ratio \>1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition; AND * Hypotension (systolic blood pressure \< 90 mm Hg sustained for more than 15 minutes; or requiring vasopressors) or cardiogenic shock due to acute pulmonary embolism. Exclusion Criteria: * Inability to ambulate independently, which is necessary to perform 6MWD (may be self-reported or as deemed by physical therapy during inpatient evaluation). * If patient requires supplemental oxygen during ambulation, this does not exclude patient from participation and will be noted during eCRF. * Prior history of pulmonary embolism * History of CTEPH or pulmonary arterial hypertension * Unable to read a questionnaire in English * Unable to return for baseline, 3- or 6-month follow-up visit * Pregnancy-associated pulmonary embolism * Life expectancy \<1 year based on comorbidities * Unable/unwilling to provide informed written consent
Where it's running
-
Mayo Clinic Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Stan Henkin, M.D. — Mayo Clinic
- Study coordinator: Stan Henkin, M.D.
- Email: Henkin.Stanislav@mayo.edu
- Phone: 507-284-8612
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization
This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.
-
Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE
This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.
-
Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk
This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.
-
Aspiration thrombectomy with the Symphony or Prodigy devices
This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.
-
PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.
This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.
-
Reperfusion options for acute pulmonary embolism
This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.